Literature DB >> 15155661

Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens.

Morten A Nielsen1, Lasse S Vestergaard, John Lusingu, Jørgen A L Kurtzhals, Haider A Giha, Berit Grevstad, Bamenla Q Goka, Martha M Lemnge, James B Jensen, Bartholomew D Akanmori, Thor G Theander, Trine Staalsoe, Lars Hviid.   

Abstract

The slow acquisition of protection against Plasmodium falciparum malaria probably reflects the extensive diversity of important antigens. The variant surface antigens (VSA) that mediate parasite adhesion to a range of host molecules are regarded as important targets of acquired protective immunity, but their diversity makes them questionable vaccine candidates. We determined levels of VSA-specific immunoglobulin G (IgG) in human plasma collected at four geographically distant and epidemiologically distinct localities with specificity for VSA expressed by P. falciparum isolates from three African countries. Plasma levels of VSA-specific IgG recognizing individual parasite isolates depended on the transmission intensity at the site of plasma collection but were largely independent of the geographical origin of the parasites. The total repertoire of immunologically distinct VSA thus appears to be finite and geographically conserved, most likely due to functional constraints. Furthermore, plasma samples frequently had high IgG reactivity to VSA expressed by parasites isolated more than 10 years later, showing that the repertoire is also temporally stable. Parasites from patients with severe malaria expressed VSA (VSASM) that were better recognized by plasma IgG than VSA expressed by other parasites, but importantly, VSASM-type antigens also appeared to show substantial antigenic homogeneity. Our finding that the repertoire of immunologically distinct VSA in general, and in particular that of VSASM, is geographically and temporally conserved raises hopes for the feasibility of developing VSA-based vaccines specifically designed to accelerate naturally acquired immunity, thereby enhancing protection against severe and life-threatening P. falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155661      PMCID: PMC415673          DOI: 10.1128/IAI.72.6.3531-3535.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome.

Authors:  Bridget A Robinson; Teresa L Welch; Joseph D Smith
Journal:  Mol Microbiol       Date:  2003-03       Impact factor: 3.501

2.  The inoculation of semi-immune Africans with sporozoites of Laverania falcipara (Plasmodium falciparum) in Liberia.

Authors:  R S BRAY; A E GUNDERS; R W BURGESS; J B FREEMAN; E ETZEL; C GUTTUSO; B COLUSSA
Journal:  Riv Malariol       Date:  1962-12

3.  Genomic representation of var gene sequences in Plasmodium falciparum field isolates from different geographic regions.

Authors:  S Kyes; H Taylor; A Craig; K Marsh; C Newbold
Journal:  Mol Biochem Parasitol       Date:  1997-08       Impact factor: 1.759

4.  Unstable malaria in Sudan: the influence of the dry season. Malaria in areas of unstable and seasonal transmission. Lessons from Daraweesh.

Authors:  T G Theander
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Nov-Dec       Impact factor: 2.184

5.  Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens.

Authors:  Michael F Ofori; Daniel Dodoo; Trine Staalsoe; Jørgen A L Kurtzhals; Kwadwo Koram; Thor G Theander; Bartholomew D Akanmori; Lars Hviid
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Identification of a conserved Plasmodium falciparum var gene implicated in malaria in pregnancy.

Authors:  J Alexandra Rowe; Sue A Kyes; Stephen J Rogerson; Hamza A Babiker; Ahmed Raza
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

7.  In vitro selection of Plasmodium falciparum 3D7 for expression of variant surface antigens associated with severe malaria in African children.

Authors:  Trine Staalsoe; Morten A Nielsen; Lasse S Vestergaard; Anja T R Jensen; Thor G Theander; Lars Hviid
Journal:  Parasite Immunol       Date:  2003 Aug-Sep       Impact factor: 2.280

8.  Two DBLgamma subtypes are commonly expressed by placental isolates of Plasmodium falciparum.

Authors:  Michal Fried; Patrick E Duffy
Journal:  Mol Biochem Parasitol       Date:  2002-07       Impact factor: 1.759

9.  Malaria and anaemia at different altitudes in the Muheza district of Tanzania: childhood morbidity in relation to level of exposure to infection.

Authors:  R Ellman; C Maxwell; R Finch; D Shayo
Journal:  Ann Trop Med Parasitol       Date:  1998-10

10.  Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants.

Authors:  P C Bull; B S Lowe; M Kortok; K Marsh
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  27 in total

1.  Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.

Authors:  Kpandja Djawe; Kieran R Daly; Sergio L Vargas; M Elena Santolaya; Carolina A Ponce; Rebeca Bustamante; Judith Koch; Linda Levin; Peter D Walzer
Journal:  Int J Infect Dis       Date:  2010-12       Impact factor: 3.623

2.  French Haemovigilance Data on Platelet Transfusion.

Authors:  Béatrice Willaert; Mai-Phuong Vo Mai; Cyril Caldani
Journal:  Transfus Med Hemother       Date:  2008-03-19       Impact factor: 3.747

3.  Malaria.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

4.  Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.

Authors:  Lea Barfod; Tina Dobrilovic; Pamela Magistrado; Pongsak Khunrae; Firmine Viwami; Jonas Bruun; Madeleine Dahlbäck; Nadia L Bernasconi; Michal Fried; Davis John; Patrick E Duffy; Ali Salanti; Antonio Lanzavecchia; Chwee Teck Lim; Nicaise Tuikue Ndam; Matthew K Higgins; Lars Hviid
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

5.  Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens.

Authors:  Rosette Megnekou; Trine Staalsoe; Diane W Taylor; Rose Leke; Lars Hviid
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children.

Authors:  Matthias Rottmann; Thomas Lavstsen; Joseph Paschal Mugasa; Mirjam Kaestli; Anja T R Jensen; Dania Müller; Thor Theander; Hans-Peter Beck
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

7.  Malaria.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Bernd Jansen; Horst Klamm; Wolf-Dieter Ludwig; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Hannelore Willkommen; Karl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2008-03-17       Impact factor: 3.747

8.  Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family.

Authors:  Louise Joergensen; Louise Turner; Pamela Magistrado; Madeleine A Dahlbäck; Lasse S Vestergaard; John P Lusingu; Martha Lemnge; Ali Salanti; Thor G Theander; Anja T R Jensen
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

9.  Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain.

Authors:  Kirsten Moll; Fredrik Pettersson; Anna M Vogt; Cathrine Jonsson; Niloofar Rasti; Sanjay Ahuja; Mats Spångberg; Odile Mercereau-Puijalon; David E Arnot; Mats Wahlgren; Qijun Chen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

10.  Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria.

Authors:  Pamela A Magistrado; John Lusingu; Lasse S Vestergaard; Martha Lemnge; Thomas Lavstsen; Louise Turner; Lars Hviid; Anja T R Jensen; Thor G Theander
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.